Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Adnan Tufail,1 Sue Lightman,1 Ahmed Kamal,2 Uwe Pleyer,3 Nuria María Gajate Paniagua,4 Corrine Dot,5,6 Xiao-Yan Li,7 Jenny Jiao,7 Jean Lou,7 Yehia Hashad7 For the CONSTANCE Study Group 1Moorfields Eye Hospital, London, UK; 2Aintree University Hospital, Liverpool, UK; 3Un...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tufail A, Lightman S, Kamal A, Pleyer U, Gajate Paniagua NM, Dot C, Li XY, Jiao J, Lou J, Hashad Y
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
corticosteroid
dexamethasone
drug delivery device
retinal vein occlusion
safety profile
uveitis
Ophthalmology
RE1-994
Accès en ligne:https://doaj.org/article/49c25c24a1c04ef4b9126cabaafb125b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/49c25c24a1c04ef4b9126cabaafb125b

Documents similaires